Hemodialysis and Peritoneal Dialysis Market

Global Hemodialysis and Peritoneal Dialysis Market Size (2023 to 2028)

The global hemodialysis and peritoneal dialysis market is estimated to grow at a CAGR of 7.14% from 2023 to 2028 and be worth USD 107.7 billion by 2028 from USD 76.29 billion in 2023.

Dialysis is a process used to remove waste from the blood when the kidneys are not working correctly. In hemodialysis, a machine named an artificial kidney or dialyzer with a special filter cleans the blood in hemodialysis. The patient's blood goes to the dialyzer by a dialysis access point. This machine filter through the membrane. Blood waste is removed from the body by washing it away with a solution known as Dialysate. The waste materials are discarded, and the blood is cleansed and returned to the body. The time taken for each dialysis is 4 hours and can be done at home.

The second type of dialysis is peritoneal dialysis. This dialysis does not require any machine for the purification of blood. In this, Dialysate enters a part of the abdomen using a catheter. The peritoneum, which surrounds your abdomen, acts as a natural filter to take the waste out of your blood. The fluid containing the filtered waste products flows through the catheter after a predetermined amount of "dwelling" time, allowing it to be safely discarded. It is used for people with kidney failure, end-stage renal disease (ESRD), Injuries, and conditions like high blood pressure, diabetes, and lupus that can damage kidneys, leading to kidney disease.

Impact of COVID-19 on the global hemodialysis and peritoneal dialysis market:

Covid-19 has spread all over the world. A significant and frequent side effect of COVID-19 is AKI. SARS-CoV-2 may cause kidney disease by binding to the ACE2 receptor on kidney cells, which allows the virus to enter. Detecting coronavirus in SARS-CoV and SARS-CoV-2 patients' kidneys and urine proves that the virus can cause direct kidney injury. Conditions such as hypertension, heart disease, diabetes, lung disease, chronic kidney disease (CKD), and immunologic diseases are at high risk of acquiring this severe infection. CKD patients are more affected by respiratory diseases. The National Kidney Foundation urges individuals with advanced kidney disease, especially those undergoing dialysis or transplantation or who require immunosuppression therapy. The burden of COVID-19 has increased because of the higher incidence of illnesses, hospitalization, and deaths. During the pandemic, patients with ESRD were of enormous importance. Due to this, the market has been positively impacted during the COVID-19 pandemic.

MARKET DRIVERS:

The growing prevalence of diabetes is majorly driving the hemodialysis and peritoneal dialysis market forward.

Diabetes can cause damage to blood vessels in the kidneys, which help to filter waste from your blood. Increased pressure in the kidneys' filtering mechanism from high blood pressure can result in additional renal damage. 87,647 death certificates with diabetes listed as the underlying cause of death indicate that diabetes was the seventh most common cause of death in the U.S. in 2019. In a total of 282,801 death certificates in 2019, diabetes was recorded as a cause of death. In addition, a shortage of donors, increasing chronic kidney disease (CKD), an increasing population of patients receiving dialysis, various government policies, and a rise in the prevalence of lifestyle diseases are propelling the growth of the hemodialysis and peritoneal dialysis market.

In addition, rising funding from the public and private sectors, advancements in healthcare infrastructure, a rise in the prevalence of the older population, and an increase in the number of dialysis centers, technological advances, and product launches are further anticipated to boost the growth rate of the hemodialysis and peritoneal dialysis market. New approaches and dialysis methods are cost-effective, accessible, and offer improved patient outcomes.

MARKET RESTRAINTS:

Side effects such as chest pain, headaches, itchy skin, muscle cramps, stringent regulatory policies, and lack of standardized treatment hamper the growth rate of the hemodialysis and peritoneal dialysis market. AKI requires a more extended hospital stay, raises the cost of the stay, and even raises the death risk. Skin infections around the catheter, and reimbursement issues, are the challenges to market growth.

REPORT COVERAGE:

This research report on the global hemodialysis and peritoneal dialysis market has been segmented based on the type, product, end-user, and region.

Hemodialysis and Peritoneal Dialysis Market – By Type:

• Hemodialysis
  • Short-term Catheter
  • Chronic Catheter
  • Graft
  • Fistula
• Peritoneal Dialysis
  • Continuous Ambulatory Peritoneal Dialysis (CAPD)
  • Automated Peritoneal Dialysis (APD)

The automated peritoneal dialysis segment, also known as continuous cycling peritoneal dialysis, accounted for the most significant share of the hemodialysis and peritoneal dialysis market in 2022. At the same time, while sleeping at night, a machine performs this type of dialysis cycle through various exchanges. The machine's abdomen is flushed with Dialysate and stays there for a while before draining into a sterile bag. Take the bag out in the morning. Each night, automated peritoneal dialysis lasts about 10 to 12 hours.

Hemodialysis and Peritoneal Dialysis Market – By Product:

• Devices
  • Machine
  • Dialyzer
  • Water treatment system
  • Others
• Consumables
  • Bloodline
  • Concentrates
  • Catheters
  • Others

Based on the product, the consumables segment had the largest share of the market in 2022. consumables such as dialyzers, AV tubing sets, fistula needles, sodium bicarbonate cartridges and bags, bicarbonate and acid concentrate solutions, endotoxin filters, and disinfectants are used in dialysis. Factors such as increasing expenditure on advanced products and increased use of dialysis treatments drive the segment forward.

Hemodialysis and Peritoneal Dialysis Market – By End-User:

• Home-based
• Hospital-based

Based on the end-user, the home-based dialysis segment led the market in 2022 due to less medication to control blood pressure and anemia, improved neuropathy, increased sleep, energy for daily tasks, and extended living. Home hemodialysis has better results than hospital hemodialysis. Home hemodialysis also provides the opportunity for more extended dialysis.

Hemodialysis and Peritoneal Dialysis Market – By Region:

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

North America accounted for a significant share of the global hemodialysis and peritoneal dialysis market in 2022. Due to the increased kidney disease in the region, North America is anticipated to hold the largest share during the forecast period. In the United States, 37 million adults, more than 1 in 7, have chronic kidney disease (CKD). Americans with diabetes and high blood pressure are the two most common causes of kidney disease. The prevalence of kidney failure in Canada has doubled in the last 20 years. Kidney failure is treated with a kidney transplant because of this form of kidney replacement therapy. The number of Canadians receiving chronic dialysis was nearly 12,547 in 2001 to 23,708 in 2020.

The Asia Pacific is expected to have a significant share of the worldwide market during the forecast period. For example, there are presently about 5,000 people with ESRD in India. These patients have two treatment options continuous ambulatory peritoneal dialysis (CAPD) at home or hemodialysis (HD) in a hospital. As of 2017, 334,505 patients had received dialysis therapy in Japan, according to the most current annual report of the Japanese Society for Dialysis Therapy Renal Data Registry. All patients in Japan are potentially eligible for treatment; the population undergoing online hemodiafiltration, particularly the predilution approach, has significantly expanded recently.

KEY MARKET PARTICIPANTS:

Fresenius Medical Care AG & Co. KGaA, Baxter International Inc., Nipro Corporation, B Braun Melsungen AG, Nikkiso Co., Ltd., Becton, Dickinson, and Company (C. R. Bard, Inc.), Cook Group, Angiodynamics Inc., Medtronic PLC, and Asahi Kasei Corp. are some of the prominent companies operating in the global hemodialysis and peritoneal dialysis market profiled in this report.

RECENT HAPPENINGS IN THIS MARKET:

• In 2022, Fresenius Medical Care, a leading provider of kidney care products in the U.S, announced that the U.S. Food and Drug Administration (FDA) had given clearance to the Versi PD Cycler System. The version is designed to improve health equity by making home therapy a more feasible option for a broader population of dialysis patients.